Clinical trial
A Multicenter, Prospective, Observational Study to Evaluate the Effectiveness and Safety of S-amlodipine-based Monotherapy and Combination Therapy in Korean Hypertensive Patients
NCT07907822 is registered in ClinicalTrials.gov with Ahn-Gook Pharmaceuticals Co.,Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective, Observational Study to Evaluate the Effectiveness and Safety of S-amlodipine-based Monotherapy and Combination Therapy in Korean Hypertensive Patients
- Lead sponsor
- Ahn-Gook Pharmaceuticals Co.,Ltd
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- November 1, 2026
- Completion date
- October 31, 2029
- Enrollment
- 4,528 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
essential (primary) hypertension, hypertension, hypertension (htn)
Arms
As registered; 2 arms.
-
Monotherapy cohort
-
Combination therapy cohort
Primary endpoints
Registered primary outcome measures; 1 primary.
-
The blood pressure control rate
The blood pressure control rate (\< 140/90 mmHg)(Systolic and Diastolic) at Week 12
Lead sponsor's other trials
Ahn-Gook Pharmaceuticals Co.,Ltd, most recent start first.
+18 more trials See the organization page
Similar trials
Same condition (Essential Hypertension) and phase, most recent start first.
+66 more trials See the condition page